Synteract Expands into Asia Pacific and South Africa


Applied Clinical Trials

Synteract has extended its existing global footprint into Asia Pacific and Africa with the acquisition of Clindata’s human health biometrics division. Financial terms of this deal were not disclosed.

For further details, click here. 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.